Dr. Reddy’s Laboratories Ltd. ADR (RDY) down -0.44% since start of the year

Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) is -0.44% lower on its value in year-to-date trading and has touched a low of $12.26 and a high of $16.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RDY stock was last observed hovering at around $15.80 in the last trading session, with the day’s loss setting it -0.08%.

Currently trading at $15.72, the stock is 4.42% and 10.98% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.11 million and changing -0.51% at the moment leaves the stock 8.21% off its SMA200. RDY registered 9.64% gain for a year compared to 6-month loss of 8.71%.

The stock witnessed a 9.24% gain in the last 1 month and extending the period to 3 months gives it a 18.91%, and is 0.58% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.59% over the week and 1.56% over the month.

Dr. Reddy’s Laboratories Ltd. ADR (RDY) has around 27811 employees, a market worth around $13.08B and $3.85B in sales. Current P/E ratio is 19.63 and Fwd P/E is 24.32. Profit margin for the company is 17.32%. Distance from 52-week low is 28.22% and -6.94% from its 52-week high. The company has generated returns on investments over the last 12 months (16.71%).

The EPS is expected to shrink by -0.27% this year.

Dr. Reddy’s Laboratories Ltd. ADR (RDY) Top Institutional Holders

The shares outstanding are 834.46M, and float is at 832.00M with Short Float at 1.71%.

The top institutional shareholder in the company is MORGAN STANLEY with over 2.03 million shares valued at $154.67 million. The investor’s holdings represent 6.0857% of the RDY Shares outstanding. As of 2024-06-30, the second largest holder is ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. with 2.07 million shares valued at $157.65 million to account for 1.2406 of the shares outstanding. The other top investors are ROYAL BANK OF CANADA which holds 2.06 million shares representing 1.2325% and valued at over $156.61 million, while RENAISSANCE TECHNOLOGIES LLC holds 1.1964 of the shares totaling 2.0 million with a market value of $152.04 million.

Dr. Reddy’s Laboratories Ltd. ADR (RDY) Insider Activity

#####

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.